Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors

NCT04324372 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Refractory Solid Tumors

Interventions

DRUG: HEC68498

Sponsor

Sunshine Lake Pharma Co., Ltd.